Compugen Appoints Mr. Ari Krashin as Chief Financial Officer

Citation metadata

Date: Sept. 13, 2014
Publisher: NewsRX LLC
Document Type: Article
Length: 456 words
Lexile Measure: 1470L

Document controls

Main content

Article Preview :

By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Compugen Ltd. (NASDAQ: CGEN), a leading drug discovery company focused on therapeutic proteins and monoclonal antibodies in the fields of immunology and oncology, announced the appointment of Mr. Ari Krashin as Chief Financial Officer, effective as of September 9, 2014. Mr. Krashin will report to Dr. Anat Cohen Dayag, Compugen's President and Chief Executive Officer, and will have direct responsibility for all financial functions of the company, including investor relations, and in addition will oversee the legal function (see also Compugen Ltd.).

Dr. Cohen-Dayag stated, "With over 15 years of experience in all aspects of finance, investor relations, M&A and business...

Source Citation

Source Citation   

Gale Document Number: GALE|A382910152